Skip to main content

Table 8 Crude Relative Risk of Venous Thromboembolism in Cisplatin based regimens

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

 

Incidence proportion

Relative Risk (95% CI)

Cisplatin group

31/200

2.81* (1.4–4.2)

Non-Cisplatin group

11/200

 
  1. *p < 0.05
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us